Sodium Citrate 40 mg/mL / Gentamicin 0 recalled over sterility concerns
- Recall date
- September 12, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- KRS Global Biotechnology, Inc recalls Sodium Citrate 40 mg/mL (4%) / Gentamicin 0.32 mg/mL. 30 mL vial for Intra-Catheter Use Only, Rx Only, KRS Global Biote…
- Recall number
- D-0102-2020
- FDA classification
- Class II
- Brand / firm
- KRS Global Biotechnology, Inc
- Sold / distributed
- Nationwide
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Sodium Citrate 40 mg/mL (4%) / Gentamicin 0.32 mg/mL. 30 mL vial for Intra-Catheter Use Only, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321676603
Get recall alerts
Free email alert whenever KRS Global Biotechnology, Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: KRS Global Biotechnology, Inc